Oncology - European Medical Journal

Continue

Oncology

Filter
17 Nov 2014

Women and Lung Cancer: Literature Assumptions and News from Recent Publications

For a long period of time, lung cancer (LC) was considered as a malignancy affecting only males, but epidemiological data have shown a dramatic increase…
17 Nov 2014

Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment

Non-Hodgkin’s lymphomas (NHLs) are a heterogeneous group of different haematological cancers with a wide range of aggressiveness. NHLs represent >80% of….
17 Nov 2014

Fundamental Principles of Raising an Antitumour Immune Response in Vivo: A Complex Model, a Case Report, and a Perspective

In preclinical model systems, the fundamental principles underlying a successful and durable anti-tumour immune response are well demonstrated.
17 Nov 2014

Immunotherapy of Cancer: Towards a New Era

In the past two decades, immunotherapy of cancer has developed into an established treatment option. At first, the development of monoclonal antibodies…
17 Nov 2014

Radiotherapy for Breast Cancer: How Can it Benefit from Advancing Technology?

There have been significant technological and technical advances in radiotherapy over the last 20 years. This paper presents the pertinent advances and…
17 Nov 2014

Management of Patients with High-Grade Glioma

The scientific basis for the surgical management of patients with glioma is rapidly evolving. The infiltrative nature of these cancers precludes a…
17 Nov 2014

State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer

Prostate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the…
EMJ
4 Mins
17 Oct 2014

Zydelig® (idelalisib): The Force to Fight CLL and FL

After the European Commission granted the marketing authorisation for Gilead’s Zydelig® (idelalisib), a first-in-class oral treatment for chronic…